Nine Cheese Hall performance wasted focus on financial management Chung-jin thinking of the withdrawal of China Resources or

Although the profitability of bank financial products has been declining, it is still difficult to block nine Zhi Tang (000989.SZ) to its favor. A few days ago, nine cheese Hall announced that the company will again spend 100 million yuan of its own idle funds to buy capital preservation of Beijing Bank products, and more than two years to recycle the company to buy financial products, the total amount of spare money amounted to 600 million yuan. A large number of spare money financing behind, but is nine in recent years performance stagnation embarrassing reality, the company 2010 years after the four years, the revenue has been hovering around 1.1 billion yuan, net profit in 200 million yuan fluctuation, and most of the pharmaceutical listed companies in the performance of the year big increase in the scene is very different. However, the 21st century Economic report reporter has recently learned from the insider's office that the nine-cheese club may be easy to master: The Chung Jin Department is considering retreat, and China Resources Medicine is interested to take a stand. "Nine Zhi Tang is the first listed company in Chung Jin Department, conferred was very emotional, but also have enough to control, but his widow Chen Jinxia is different, she has no experience in industrial operation, whether the level or control ability and his husband is far apart, how can hold the existing stall? "The Hunan Capital industry personage evaluates." In addition, the lack of exclusive core products, the lack of marketing talent, high level of frequent shocks is also the nine Cheese Hall performance of the important reasons. Performance problems to be solved 2002, Chung Jin group into nine Zhi Tang, since then, nine Zhi Tang became an important capital operation platform, in the capital market for a moment invincible. However, the conferred died in 2008, nine cheese Hall also scenery no longer. Earnings showed that from 2010 to 2012, nine Zhi Tang revenue and net profit of 1.122 billion yuan, 1.149 billion yuan, 1.042 billion yuan and 163 million yuan, 202 million yuan, 112 million yuan, compared to most pharmaceutical listed companies, its performance is in situ. And nine Zhi Tang's Raise investment project is also mess. In 2003, the company raised 510 million yuan of funds, until 2012, all used up. Most of the initial projects were changed or terminated, as at the end of 2012, 1 of the 13 projects were discontinued, 4 terminated, 2 were under construction, one transfer, and only 3 achieved the expected benefits. Nine Cheese Hall product line is long, lacks the exclusive core product, the localization is ambiguous and the marketing weakness is the main short board. "Hunan Medicine industry personage said, nine cheese Hall main product is six Dihuang pill and donkey gum blood enriching granules, although these two product sales both exceed 200 million yuan, but is not the exclusive product, the market competition is very intense." The management of nine cheese halls has changed frequently in recent years: August 2009, the 55-year-old chairman of the nine Yukejian resigned, the original general manager Guanji successor chairman, General Manager Assistant Liu Zhitao successor General manager; May 2010, the company again personnel concussion, Guanji, Dong Secret Cai Guangyun, Chief Engineer He Guoping and other senior executives resigned, conferred elder brother Wei Airborne nine Zhi Tang pro-ren chairman. February 2012, is regarded as Chen Jinxia confidant of Liu Zhitao, former general manager, Donga Donkey-hide-gelatin (000423.SZ) Deputy General manager Cheng Jizhong Airborne Nine Zhi Tong as general manager. However, the process did not make the nine Cheese Hall performance heavyHuan Vitality, also in April 2013 sadly Ching, Dong Xu Xiangping successor general manager. Chung Kings to withdraw resources? With the loss of conferred's extensive connections, the Chen Jinxia-led Chung-jin system began to lose in the capital markets, with its investment in the round-wheel stake, the two-letter IPO being seen as evidence. At the same time, Chung Jin Department analysts a large number of job-hopping, high-level shocks, the failure of the IPO and other negative news. In this context, the Chung Jin department to abandon mismanagement, but also not the core business of the nine Cheese Hall, it seems reasonable. In the first half of 2013, there were rumours that Chung Jin department had deliberately withdrawn from nine cheese halls, when Wei, chairman of nine Cheese Hall, had indicated that he had contacted, but denied that he had reached an intention. However, the insider said, the current Chung Jin department has begun to do to sell nine cheese Hall preparation, and the possible intention is the state-owned resources group. Data show that China Resources Group's business covers electricity, finance, cement, consumer goods, medicine in a number of areas, its pharmaceutical sector currently has Huarun 39 (000999.SZ), Huarun double cranes (600062.SH), China Resources Wandong (600055.SH), Donga Donkey-hide gelatin several listed companies. "China resources in the pharmaceutical industry is rich in experience, such as the China Resources Double Crane main business is also drug manufacturing and chain sales, and nine Zhi Tong is similar, and China Resources marketing ability is also good, if China resources to take over, do not rule out the nine Zhi Tang to create a similar Donga donkey-hide gelatin such "The analysis of the medical profession. And China Resources prior to nine Cheese Hall already have intersection. Nine Zhi Tong reported that the company 2012 the first major customer for the Changsha double Crane Medicine, sales of 26.5285 million yuan, while the Changsha double Crane Medicine prior to the China Resources Double Crane holding subsidiary, September 2013, China Resources Double cranes will be held in Changsha Double crane 66.954% transfer to China Resources Medicine Group.